Association of baseline HBcAg and HBV DNA with persistent detectability of HBV RNA during NA therapy
Lanjie Wu, Zixiang Pan, Jianli Yu, Xitan Yue, Fang He, Lili Yu, Ling Pan, Yuyan Wu · 2026
Read Association of baseline HBcAg and HBV DNA with persistent detectability of HBV RNA during NA therapy by Lanjie Wu, Zixiang Pan, Jianli Yu, Xitan Yue, Fang He, Lili Yu, Ling Pan, Yuyan Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352870.txt.
Description
Lanjie Wu and seven co-authors present this 2026 PLOS One study of chronic hepatitis B. Many patients on long-term antiviral pills fully suppress the virus's DNA. Yet their blood still carries viral RNA. That RNA is a sign the virus stays active inside the liver. The team reviewed one hundred fifty-five patients who had liver biopsies before treatment. They hunted for baseline traits that predict the lingering RNA signal.
Just under half the patients cleared the RNA. Two baseline traits predicted persistence on their own. One was higher starting viral DNA. The other was the absence of a viral core protein in the liver sample. The pair predicted better than either trait alone. The authors suggest the pairing could help doctors tailor treatment and monitoring. It suits patients whose virus refuses to go fully quiet.
Catalog record
| CREATOR | Lanjie Wu, Zixiang Pan, Jianli Yu, Xitan Yue, Fang He, Lili Yu, Ling Pan, Yuyan Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25718 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |